22717

    544122

    ENTERO

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ENTERO HEALTHCARE SOLU L Share Price Today

    ENTERO HEALTHCARE SOLU L is currently trading at ₹1242.7, up by ₹0.19 from the previous close. The stock touched an intraday high of ₹1266.00 and a low of ₹1230.00 during the latest trading session. Over the past one year, ENTERO HEALTHCARE SOLU L has delivered a loss of 1.22%, while the stock has gained 2.69% in the last one month.

    ENTERO HEALTHCARE SOLU L performance

    Today’s low Today’s high
    ₹ 1230.00 ₹ 1266.00
    ₹ 1242.70
    52 week low 52 week high
    ₹ 944.00 ₹ 1390.00
    ₹ 1242.70
    Open Price ₹ 1238.00
    Prev. Close ₹ 1242.50
    Volume (Shares) 46032.00
    Total traded value ₹ 572.03
    Upper Circuit ₹ 1491.00
    Lower Circuit ₹ 994.00
    info

    Investment Returns

    Over 1 Month 2.69% Over 3 Months -1.81% Over 6 Months 6.86% Over 1 Year -1.22%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ENTERO HEALTHCARE SOLU L fundamentals


    • Market cap (Cr) 5,408.60
    • P/E Ratio (TTM) 201.86
    • Beta 0.25
    • Book Value / share 385.22
    • Return on equity 1.74%
    • EPS (TTM) 6.71
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 3.46
    info icon alternate text
    • Market cap (Cr) 5,420.60
    • P/E Ratio (TTM) 201.86
    • Beta 0.22
    • Book Value / share 385.22
    • Return on equity 1.74%
    • EPS (TTM) 6.71
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 3.46
    info icon alternate text

    ENTERO HEALTHCARE SOLU L Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 83.27
    Operating Expense 101.80
    Net Profit 3.46
    Net Profit Margin (%) 4.15
    Earnings Per Share (EPS) 0.79
    EBITDA 13.46
    Effective Tax Rate (%) 24.94
    Particulars MAR 2026 (Values in Cr)
    Revenue 78.93
    Operating Expense 106.85
    Net Profit 13.42
    Net Profit Margin (%) 17.00
    Earnings Per Share (EPS) 3.08
    EBITDA 17.41
    Effective Tax Rate (%) -11.46
    Particulars DEC 2025 (Values in Cr)
    Revenue 106.74
    Operating Expense 124.12
    Net Profit 0.81
    Net Profit Margin (%) 0.75
    Earnings Per Share (EPS) 0.18
    EBITDA 4.87
    Effective Tax Rate (%) 41.60
    Particulars SEP 2025 (Values in Cr)
    Revenue 83.22
    Operating Expense 99.83
    Net Profit 5.70
    Net Profit Margin (%) 6.84
    Earnings Per Share (EPS) 1.31
    EBITDA 11.64
    Effective Tax Rate (%) 25.09
    Particulars JUN 2025 (Values in Cr)
    Revenue 79.35
    Operating Expense 96.47
    Net Profit 6.96
    Net Profit Margin (%) 8.77
    Earnings Per Share (EPS) 1.60
    EBITDA 12.57
    Effective Tax Rate (%) 24.12
    Particulars MAR 2026 (Values in Cr)
    Revenue 348.24
    Operating Expense 427.28
    Net Profit 26.88
    Net Profit Margin (%) 7.71
    Earnings Per Share (EPS) 6.18
    EBITDA 46.52
    Effective Tax Rate (%) 10.96
    Particulars MAR 2025 (Values in Cr)
    Revenue 408.67
    Operating Expense 449.18
    Net Profit 19.18
    Net Profit Margin (%) 4.69
    Earnings Per Share (EPS) 4.41
    EBITDA 36.95
    Effective Tax Rate (%) 28.37
    Particulars MAR 2024 (Values in Cr)
    Revenue 318.16
    Operating Expense 383.71
    Net Profit 38.44
    Net Profit Margin (%) 12.08
    Earnings Per Share (EPS) 10.63
    EBITDA 55.44
    Effective Tax Rate (%) -57.77
    Particulars MAR 2023 (Values in Cr)
    Revenue 177.69
    Operating Expense 242.71
    Net Profit -12.46
    Net Profit Margin (%) -7.01
    Earnings Per Share (EPS) -30.28
    EBITDA 8.64
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 137.29
    Operating Expense 205.01
    Net Profit -40.85
    Net Profit Margin (%) -29.75
    Earnings Per Share (EPS) -0.72
    EBITDA -26.85
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 386.61
    ROE % 8.55
    ROCE % 10.27
    Total Debt to Total Equity 0.31
    EBITDA Margin 4.20
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 395.31
    ROE % 6.33
    ROCE % 8.70
    Total Debt to Total Equity 0.22
    EBITDA Margin 4.14
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 376.21
    ROE % 4.96
    ROCE % 6.63
    Total Debt to Total Equity 0.35
    EBITDA Margin 3.22
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -166.80
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.69
    EBITDA Margin 2.11
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share -150.52
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.53
    EBITDA Margin 1.15
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 385.33
    ROE % 1.74
    ROCE % 2.14
    Total Debt to Total Equity 0.04
    EBITDA Margin 14.30
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 378.35
    ROE % 3.49
    ROCE % 4.43
    Total Debt to Total Equity 0.01
    EBITDA Margin 20.50
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 373.53
    ROE % 4.83
    ROCE % 3.91
    Total Debt to Total Equity 0.06
    EBITDA Margin 17.42
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -194.27
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.15
    EBITDA Margin 4.87
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share -176.06
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.08
    EBITDA Margin -19.55
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 161.78
    Total Assets 3600.26
    Total Liabilities 3600.26
    Total Equity 1752.54
    Share Outstanding 4
    Price to Book Ratio 3.23
    Return on Assets (%) 3.19
    Return on Capital (%) 4.96
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 260.42
    Total Assets 2702.51
    Total Liabilities 2702.51
    Total Equity 1770.35
    Share Outstanding 4
    Price to Book Ratio 3.00
    Return on Assets (%) 3.50
    Return on Capital (%) 4.58
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 893.18
    Total Assets 2344.97
    Total Liabilities 2344.97
    Total Equity 1641.38
    Share Outstanding 4
    Price to Book Ratio 2.64
    Return on Assets (%) 1.66
    Return on Capital (%) 2.04
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 106.84
    Total Assets 1308.72
    Total Liabilities 1308.72
    Total Equity 597.66
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -0.88
    Return on Capital (%) -1.19
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 105.39
    Total Assets 1125.98
    Total Liabilities 1125.98
    Total Equity 563.21
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -2.65
    Return on Capital (%) -3.53
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 58.29
    Total Assets 2157.66
    Total Liabilities 2157.66
    Total Equity 1683.03
    Share Outstanding 4
    Price to Book Ratio 3.23
    Return on Assets (%) 1.24
    Return on Capital (%) 1.5
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 170.06
    Total Assets 1803.53
    Total Liabilities 1803.53
    Total Equity 1650.38
    Share Outstanding 4
    Price to Book Ratio 3.00
    Return on Assets (%) 1.06
    Return on Capital (%) 1.16
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 792.35
    Total Assets 1768.58
    Total Liabilities 1768.58
    Total Equity 1626.41
    Share Outstanding 4
    Price to Book Ratio 2.64
    Return on Assets (%) 2.17
    Return on Capital (%) 2.36
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 77.18
    Total Assets 763.56
    Total Liabilities 763.56
    Total Equity 583.73
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -1.63
    Return on Capital (%) -1.84
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 88.24
    Total Assets 654.08
    Total Liabilities 654.08
    Total Equity 551.20
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -6.24
    Return on Capital (%) -7.03
    Particulars MAR 2026 (Values in Cr)
    Net Income 179.33
    Cash from Operations 149.95
    Cash from Investing -303.05
    Cash from Financing 123.65
    Net change in Cash -83.19
    Free Cash Flow 217.49
    Particulars MAR 2025 (Values in Cr)
    Net Income 138.73
    Cash from Operations -38.72
    Cash from Investing 219.80
    Cash from Financing -73.66
    Net change in Cash 69.27
    Free Cash Flow -27.41
    Particulars MAR 2024 (Values in Cr)
    Net Income 35.55
    Cash from Operations -23.55
    Cash from Investing -705.12
    Cash from Financing 862.94
    Net change in Cash 121.20
    Free Cash Flow -18.13
    Particulars MAR 2023 (Values in Cr)
    Net Income -3.68
    Cash from Operations -32.88
    Cash from Investing -48.59
    Cash from Financing 72.76
    Net change in Cash -21.14
    Free Cash Flow -27.36
    Particulars MAR 2022 (Values in Cr)
    Net Income -19.81
    Cash from Operations -24.36
    Cash from Investing -161.73
    Cash from Financing 211.19
    Net change in Cash 14.19
    Free Cash Flow -14.49
    Particulars MAR 2026 (Values in Cr)
    Net Income 30.18
    Cash from Operations -55.81
    Cash from Investing -132.27
    Cash from Financing 97.58
    Net change in Cash -94.41
    Free Cash Flow -40.26
    Particulars MAR 2025 (Values in Cr)
    Net Income 26.78
    Cash from Operations -92.36
    Cash from Investing 207.74
    Cash from Financing -40.88
    Net change in Cash 57.84
    Free Cash Flow -90.38
    Particulars MAR 2024 (Values in Cr)
    Net Income 24.36
    Cash from Operations -73.85
    Cash from Investing -762.69
    Cash from Financing 925.56
    Net change in Cash 87.22
    Free Cash Flow -72.81
    Particulars MAR 2023 (Values in Cr)
    Net Income -12.45
    Cash from Operations -54.37
    Cash from Investing -58.29
    Cash from Financing 91.11
    Net change in Cash -24.08
    Free Cash Flow -53.85
    Particulars MAR 2022 (Values in Cr)
    Net Income -40.84
    Cash from Operations -43.73
    Cash from Investing -68.79
    Cash from Financing 127.47
    Net change in Cash 13.98
    Free Cash Flow -41.15
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 19.35 2.25 357.34 23.12 47.39
    BLISS GVS PHARMA LTD. 477.10 38.41 4.24 5068.90 118.35 552.90
    CIPLA LTD 1472.00 33.23 3.45 118914.83 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 559.55 26.17 4.05 1646.81 256.40 568.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 32.61 6.00 357.34 23.12 47.39
    AMRUTANJAN HEALTH CARE LTD. 522.95 23.44 4.08 1511.88 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8188.15 107.01 23.45 20470.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 477.10 51.63 4.38 5068.90 118.35 552.90

    ENTERO HEALTHCARE SOLU L shareholding pattern

    Holding
    27.75%
    52.4%
    4.36%
    15.47%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ENTERO HEALTHCARE SOLU L Technicals Summary

    1242.70 0.01 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1242.70
    • 26 Days 1222.00
    • 10 Days 1238.70
    • 50 Days 1207.10
    • 12 Days 1236.60
    • 100 Days 1188.50
    • 20 Days 1227.90
    • 200 Days 1178.70
    1247.83 PIVOT
    First Support 1220.67 First Resistance 1269.67 Second Support 1198.83 Second Resistance 1296.83 Third Support 1171.67 Third Resistance 1318.67
    RSI 54.49 ADX 19.59 MACD 14.61 Williams % R -44.66 Commodity Channel Index (CCI) 62.15
    Date 2026-08-07 Week 47019.00 Same Day 23662.00 Month 42732.00
    1 Year 0.25 3 Year 0.40
    Over 1 Month
    2.69% down
    Over 1 Year
    -1.22% down
    Over 3 Months
    -1.81% down
    Over 3 Years
    2.63% down
    Over 6 Months
    6.86% down
    Over 5 Years
    0.00% down

    ENTERO HEALTHCARE SOLU L Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Entero Healthcare Solutions Ltd?

    Answer Field

    Entero Healthcare Solutions Ltd share price is for NSE ₹ 1,242.70 & for BSE ₹ 1,247.85 as on Aug 07 2026 03:30 PM.

    What is the Market Cap of Entero Healthcare Solutions Ltd Share?

    Answer Field

    The market cap of Entero Healthcare Solutions Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 03:30 PM.

    What is the 52 Week High and Low of Entero Healthcare Solutions Ltd?

    Answer Field

    The 52 Week High and Low of Entero Healthcare Solutions Ltd for NSE is ₹ 1,390.00 and ₹ 944.00 and for BSE is ₹ 1,390.00 and ₹ 944.00.

    What is 1 year return for Entero Healthcare Solutions Ltd?

    Answer Field

    The 1 year returns on the stock has been -1.22%.

    What is the P/E Ratio of Entero Healthcare Solutions Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM the price-to-earnings (PE) ratio for Entero Healthcare Solutions Ltd share is 201.86.

    What is the PB ratio of Entero Healthcare Solutions Ltd Share?

    Answer Field

    As on Aug 07 2026 03:30 PM, the price-to-book (PB) ratio for Entero Healthcare Solutions Ltd share is 385.22.

    How to Buy Entero Healthcare Solutions Ltd Share?

    Answer Field

    You can trade in Entero Healthcare Solutions Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Entero Healthcare Solutions Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Entero Healthcare Solutions Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Entero Healthcare Solutions Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |